Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-17
SponsorFondation Lenval

About this trial

Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and heart rates (HR) using the absorption of light by the blood to define these signals. In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. However, it has never been studied in pediatric patients. The objective is to evaluate the remote photoplethysmography technology to measure vital signs in pediatrics

Eligibility criteria

Qualifiers

Children under 18 and over 3 years of age

Any reason for consultation or hospitalization

Written and signed informed consent from one parent or the person with parental authority,

Membership of a social security scheme

Disqualifiers

Patient with a neurocognitive disorder

Patient in immediate vital distress,

Known cardiac arrhythmia,

Scleroderma

Trial design

Treatments tested in this trial

  • Remote photoplethysmography for physiological parameters

Treatment groups

600 Participants
are divided into 1 treatment group

Sponsors and collaborators